Acurx Pharmaceuticals, Inc.
ACXP
$1.42
-$0.01-0.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.25M | -1.68M | -1.58M | -1.99M | -2.25M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 281.50K | 319.30K | 375.80K | 339.90K | 410.40K |
| Change in Net Operating Assets | 262.70K | -45.80K | 17.70K | -228.00K | 165.30K |
| Cash from Operations | -1.71M | -1.41M | -1.18M | -1.88M | -1.67M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.08M | 3.14M | 2.98M | 1.72M | 3.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.80K | -28.80K | -145.00K | -1.00K | -- |
| Cash from Financing | 3.11M | 3.11M | 2.83M | 1.72M | 3.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.40M | 1.70M | 1.65M | -157.30K | 1.42M |